53 results
Page 2 of 3
S-4
EX-10.8
9q0 tenmw
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
8-K
EX-10.5
ei57k
15 Dec 20
Anchiano Therapeutics and Chemomab Announce Entry Into
3:34pm
8-K
EX-10.2
r8f43 eh8oxtg8e
15 Dec 20
Anchiano Therapeutics and Chemomab Announce Entry Into
3:34pm
8-K
EX-10.1
j5iycd8
15 Dec 20
Anchiano Therapeutics and Chemomab Announce Entry Into
3:34pm
8-K
EX-10.4
ao7i94 lsn2
15 Dec 20
Anchiano Therapeutics and Chemomab Announce Entry Into
3:34pm
8-K
EX-10.3
xw2ww yex4v4
15 Dec 20
Anchiano Therapeutics and Chemomab Announce Entry Into
3:34pm
DEFA14A
EX-10.3
feac8muyrl5z6klg
15 Dec 20
Additional proxy soliciting materials
3:32pm
DEFA14A
EX-10.2
lx44s
15 Dec 20
Additional proxy soliciting materials
3:32pm
DEFA14A
EX-10.5
trvn2m 9mi91ji9
15 Dec 20
Additional proxy soliciting materials
3:32pm
DEFA14A
EX-10.1
rqm3v3r4
15 Dec 20
Additional proxy soliciting materials
3:32pm
DEFA14A
EX-10.4
obf3mje qvhdl118jxr8
15 Dec 20
Additional proxy soliciting materials
3:32pm
6-K
EX-10.1
jfac078e2uub wi48089
23 Sep 19
Anchiano Therapeutics Enters into An Exclusive Option To License Agreement for Novel Pan-RAS Inhibitor and PDE10/β-catenin Inhibitor Programs
5:29pm
F-1/A
EX-10.1
63a3k35qhl5gh
11 Feb 19
Registration statement (foreign) (amended)
9:52am
F-1/A
EX-10.3
bqa56
5 Feb 19
Registration statement (foreign) (amended)
5:30pm
F-1/A
EX-10.4
2qwgk h44z
31 Jan 19
Registration statement (foreign) (amended)
12:00am
F-1
EX-10.5
c7ly0ppo
7 Jan 19
Registration statement (foreign)
5:11pm
F-1
EX-10.6
sp3qj2
7 Jan 19
Registration statement (foreign)
5:11pm
F-1
EX-10.8
rylh sh4ymjc
7 Jan 19
Registration statement (foreign)
5:11pm
F-1
EX-10.2
sq7l1
7 Jan 19
Registration statement (foreign)
5:11pm
F-1
EX-10.10
4h5kh8w6
7 Jan 19
Registration statement (foreign)
5:11pm